Comerica Bank
PACB icon

Comerica Bank’s Pacific Biosciences PACB Stock Holding History

Comerica Bank’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.42K Sell
1,827
-169
-8% -$325 ﹤0.01% 3471
2025
Q3 		$2.56K Sell
1,996
-526
-21% -$712 ﹤0.01% 3495
2025
Q2 		$3.13K Hold
2,522
– – ﹤0.01% 3442
2025
Q1 		$2.98K Hold
2,522
– – ﹤0.01% 3408
2024
Q4 		$4.62K Sell
2,522
-813
-24% -$1.59K ﹤0.01% 3332
2024
Q3 		$5.67K Buy
3,335
+112
+3% +$184 ﹤0.01% 3298
2024
Q2 		$4.42K Sell
3,223
-1,172
-27% -$2.37K ﹤0.01% 3327
2024
Q1 		$16.5K Sell
4,395
-1,457
-25% -$8.53K ﹤0.01% 3081
2023
Q4 		$57.4K Buy
5,852
+402
+7% +$3.29K ﹤0.01% 2679
2023
Q3 		$45.5K Buy
+5,450
New +$62.3K ﹤0.01% 2735
2021
Q4 		– Sell
-124,020
Closed -$3.16M – 2185
2021
Q3 		$3.16M Sell
124,020
-8,580
-6% -$254K 0.02% 977
2021
Q2 		$3.42M Buy
132,600
+67,002
+102% +$1.95M 0.02% 954
2021
Q1 		$2.03M Buy
65,598
+59,766
+1,025% +$2.09M 0.01% 1343
2020
Q4 		$218K Buy
+5,832
New +$99.1K ﹤0.01% 2231

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Comerica Bank's PACB Position: Q4 2025 in Review

Comerica Bank reduced its Pacific Biosciences (PACB) stake by 8.5% in Q4 2025, selling an estimated $325 and leaving 1,827 shares worth $3.42K. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

Comerica Bank first reported a position in PACB in Q4 2020 and has held it in 14 quarters since. The position peaked at $3.42M in Q2 2021. 215 funds tracked by Wall St. Rank hold PACB as of Q4 2025.

  • Comerica Bank held 1,827 shares of Pacific Biosciences worth $3.42K as of Q4 2025.
  • Comerica Bank sold 169 Pacific Biosciences shares in Q4 2025, an estimated $325.
  • Pacific Biosciences made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3471 holding.
  • Comerica Bank first reported a position in Pacific Biosciences in Q4 2020 and has held it in 14 quarters since.
  • Comerica Bank's Pacific Biosciences position peaked at $3.42M in Q2 2021.
  • 215 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.